Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edoardo Sciatti

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
European Journal of Preventive Cardiology|May 14, 2020
Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19Edoardo Sciatti, Claudio Ceconi
European Journal of Preventive Cardiology|February 13, 2021
The strange case of hydroxychloroquine and COVID-19Edoardo Sciatti, Claudio Ceconi
Giornale Italiano Di Cardiologia (2006)|October 30, 2023
[The STEP-HFpEF trial: proof of concept that phenotypic therapy in heart failure with preserved ejection fraction can really be a valid therapeutic solution?]Michele Senni, Edoardo Sciatti
JAMA Cardiology|June 16, 2021
A Still-Ignored Cardiovascular Risk Factor-A History of PreeclampsiaEdoardo Sciatti, Rossana Orabona
European Journal of Preventive Cardiology|March 20, 2020
Diabetes mellitus and chronic kidney disease: A neglected and dangerous liaisonEdoardo Sciatti, Claudio Ceconi
European Journal of Preventive Cardiology|May 19, 2020
A window of opportunity on cardiovascular prevention: pre-eclampsia and fetal growth restrictionEdoardo Sciatti, Rossana Orabona
Journal of the American College of Cardiology|July 2, 2021
Cardiovascular Prevention After Hypertensive Disorders of Pregnancy: Do Not Forget Fetal Growth Restriction!Edoardo Sciatti, Rossana Orabona
Journal of the American College of Cardiology|April 8, 2022
When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEFEdoardo Sciatti, Rossana Orabona
Obstetrics and Gynecology|February 22, 2020
Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular MorbidityRossana Orabona, Edoardo Sciatti, Federico Prefumo
Therapeutic Advances in Cardiovascular Disease|July 3, 2020
Ivabradine and endothelium: an updateLucia Dallapellegrina, Edoardo Sciatti, Enrico Vizzardi
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
European Journal of Preventive Cardiology|May 14, 2020
Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19Edoardo Sciatti, Claudio Ceconi
European Journal of Preventive Cardiology|February 13, 2021
The strange case of hydroxychloroquine and COVID-19Edoardo Sciatti, Claudio Ceconi
Giornale Italiano Di Cardiologia (2006)|October 30, 2023
[The STEP-HFpEF trial: proof of concept that phenotypic therapy in heart failure with preserved ejection fraction can really be a valid therapeutic solution?]Michele Senni, Edoardo Sciatti
JAMA Cardiology|June 16, 2021
A Still-Ignored Cardiovascular Risk Factor-A History of PreeclampsiaEdoardo Sciatti, Rossana Orabona
European Journal of Preventive Cardiology|March 20, 2020
Diabetes mellitus and chronic kidney disease: A neglected and dangerous liaisonEdoardo Sciatti, Claudio Ceconi
European Journal of Preventive Cardiology|May 19, 2020
A window of opportunity on cardiovascular prevention: pre-eclampsia and fetal growth restrictionEdoardo Sciatti, Rossana Orabona
Journal of the American College of Cardiology|July 2, 2021
Cardiovascular Prevention After Hypertensive Disorders of Pregnancy: Do Not Forget Fetal Growth Restriction!Edoardo Sciatti, Rossana Orabona
Journal of the American College of Cardiology|April 8, 2022
When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEFEdoardo Sciatti, Rossana Orabona
Obstetrics and Gynecology|February 22, 2020
Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular MorbidityRossana Orabona, Edoardo Sciatti, Federico Prefumo
Therapeutic Advances in Cardiovascular Disease|July 3, 2020
Ivabradine and endothelium: an updateLucia Dallapellegrina, Edoardo Sciatti, Enrico Vizzardi
Pageof 13